admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Mindset Pharma and Top Psychiatric Research Hospital, CAMH, Enter Innovative Collaboration...

Yale’s Department of Psychiatry Chair to Join Clearmind Medicine

Diamond Therapeutics Achieves Last Patient Last Visit in Clinical Trial of...

Gilgamesh Announces Clinical Candidates For Two Programs With First In Human...

Bexson Biomedical to present at the H.C. Wainwright and Beryl Elites...

Psilera Expands Computational Chemistry Abilities with the Addition of Dr. Daniel...

Danish Synthetic Biology Drug Developer Octarine and British Clinical Research Organisation...

CB Therapeutics granted a new patent that will help further provide...

Wake Network, Inc. Receives Certificate of Drug Registration for Microdose Formulation...

Ehave, Inc. Announces its KetaDASH Mobile Unit will be Delivered to...

1...138139140...218 Page 139 of 218

EDITOR PICKS

After the Readout: How the Field Is Interpreting Compass’ Phase 3...

Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts

Compass Provides Fuller Phase 3 Picture, MADRS Curves, on Webcast

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin